Archived documents

FDAOther

Clinical Pharmacology Considerations for Peptide Drug Products Guidance for Industry - DRAFT GUIDANCE

CDCNotice

Notice of an Amended Order Under Sections 362 and 365 of the Public Health Service Act Suspending Introduction of Certain Persons From Countries Where a Communicable Disease Exists

DEAProposed Rule

Schedules of Controlled Substances: Placement of Diphenidine in Schedule I

CDCNotice

Advancing Violence Epidemiology in Real-Time (AVERT) 2026-10513

CMSNotice

CMS-10249 ( Administrative Requirements for Section 6071 of the Deficit Reduction Act)

CMSRFI

Request for Information: Comprehensive Regulations to Uncover Suspicious Healthcare

DEANotice

2026-08586

CDCNotice

Message Testing for Tobacco Communication Activities 2026-08670

FDANotice

Advancing the Use of Digital Health Technologies in Clinical Investigations for Drugs and Biological Products; Request for Information and Comments

CDCNotice

National Center for Health Statistics (NCHS) Data Detectives Camp

CDCNotice

[NCHS] National Survey of Family Growth (NSFG) 2026-07759

CDCNotice

Notice of Order Under Sections 362 and 365 of the Public Health Service Act Suspending Introduction of Certain Persons From Countries Where a Communicable Disease Exists